Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Delorme
Friedhelm Raue

Showing results (41-50 of 232) with videos related to

Pageof 24
Sort By:
Der Radiologe|January 16, 2021
[Imaging in oncology : What is good, should improve]Stefan Delorme, Christian Herold
Der Radiologe|May 1, 2007
["Graduate education, certified continuing education" in radiology]Stefan Delorme, Maximilian Reiser
Radiologie (Heidelberg, Germany)|October 24, 2024
[Forensic radiology]Stefan Delorme, Sarah Heinze
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|April 22, 2011
Imaging in multiple myelomaStefan Delorme, Andrea Baur-Melnyk
European Journal of Radiology|March 11, 2009
Imaging in multiple myelomaStefan Delorme, Andrea Baur-Melnyk
Clinical Chemistry and Laboratory Medicine|July 13, 2021
Procalcitonin measured by three different assays is an excellent tumor marker for the follow-up of patients with medullary thyroid carcinomaJürgen Kratzsch, Anja Willenberg, Karin Frank-Raue, et al.
Clinical Endocrinology|February 6, 2008
Difference in development of medullary thyroid carcinoma among carriers of RET mutations in codons 790 and 791Karin Frank-Raue, Andreas Machens, Christian Scheuba, et al.
Radiologie (Heidelberg, Germany)|November 26, 2025
[Pediatric chest radiology: Choose wisely]Hans-Joachim Mentzel, Stefan Delorme
Radiologie (Heidelberg, Germany)|May 15, 2023
[Radiological imaging in CUP syndrome]Felix T Kurz, Stefan Delorme
The Journal of Clinical Endocrinology and Metabolism|May 5, 2005
Coincidence of multiple endocrine neoplasia types 1 and 2: mutations in the RET protooncogene and MEN1 tumor suppressor gene in a family presenting with recurrent primary hyperparathyroidismKarin Frank-Raue, Susanne Rondot, Wolfgang Hoeppner, et al.
Pageof 24

Showing results (41-50 of 232) with videos related to

Sort By:
Pageof 24
Der Radiologe|January 16, 2021
[Imaging in oncology : What is good, should improve]Stefan Delorme, Christian Herold
Der Radiologe|May 1, 2007
["Graduate education, certified continuing education" in radiology]Stefan Delorme, Maximilian Reiser
Radiologie (Heidelberg, Germany)|October 24, 2024
[Forensic radiology]Stefan Delorme, Sarah Heinze
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|April 22, 2011
Imaging in multiple myelomaStefan Delorme, Andrea Baur-Melnyk
European Journal of Radiology|March 11, 2009
Imaging in multiple myelomaStefan Delorme, Andrea Baur-Melnyk
Clinical Chemistry and Laboratory Medicine|July 13, 2021
Procalcitonin measured by three different assays is an excellent tumor marker for the follow-up of patients with medullary thyroid carcinomaJürgen Kratzsch, Anja Willenberg, Karin Frank-Raue, et al.
Clinical Endocrinology|February 6, 2008
Difference in development of medullary thyroid carcinoma among carriers of RET mutations in codons 790 and 791Karin Frank-Raue, Andreas Machens, Christian Scheuba, et al.
Radiologie (Heidelberg, Germany)|November 26, 2025
[Pediatric chest radiology: Choose wisely]Hans-Joachim Mentzel, Stefan Delorme
Radiologie (Heidelberg, Germany)|May 15, 2023
[Radiological imaging in CUP syndrome]Felix T Kurz, Stefan Delorme
The Journal of Clinical Endocrinology and Metabolism|May 5, 2005
Coincidence of multiple endocrine neoplasia types 1 and 2: mutations in the RET protooncogene and MEN1 tumor suppressor gene in a family presenting with recurrent primary hyperparathyroidismKarin Frank-Raue, Susanne Rondot, Wolfgang Hoeppner, et al.
Pageof 24